Prediction of chemo-response in serous ovarian cancer

BACKGROUND: Nearly one-third of serous ovarian cancer (OVCA) patients will not respond to initial treatment with surgery and chemotherapy and die within one year of diagnosis. If patients who are unlikely to respond to current standard therapy can be identified up front, enhanced tumor analyses and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer
Main Authors: Gonzalez Bosquet, Jesus, Newtson, Andreea M., Chung, Rebecca K., Thiel, Kristina W., Ginader, Timothy, Goodheart, Michael J., Leslie, Kimberly K., Smith, Brian J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070116/
https://ncbi.nlm.nih.gov/pubmed/27756408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0548-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados